Technical Analysis for CDAK - Codiak BioSciences, Inc.

Grade Last Price % Change Price Change
D 26.6 2.82% 0.73
CDAK closed up 2.82 percent on Friday, January 22, 2021, on 39 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Down
Historical CDAK trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 20 DMA Bearish 2.82%
Wide Bands Range Expansion 2.82%
20 DMA Support Bullish -2.74%
Wide Bands Range Expansion -2.74%
Multiple of Ten Bearish Other -6.44%
Wide Bands Range Expansion -6.44%
Older End-of-Day Signals for CDAK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Biology Diseases Disease Urology Neurology Infectious Disease Exosome Neuromuscular Disease Vesicles

Is CDAK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.85
52 Week Low 7.9
Average Volume 269,606
200-Day Moving Average 0.00
50-Day Moving Average 18.79
20-Day Moving Average 27.52
10-Day Moving Average 28.12
Average True Range 3.39
ADX 46.41
+DI 28.34
-DI 18.43
Chandelier Exit (Long, 3 ATRs ) 27.67
Chandelier Exit (Short, 3 ATRs ) 25.58
Upper Bollinger Band 33.58
Lower Bollinger Band 21.46
Percent B (%b) 0.42
BandWidth 44.03
MACD Line 2.44
MACD Signal Line 3.24
MACD Histogram -0.8047
Fundamentals Value
Market Cap 494.61 Million
Num Shares 18.6 Million
EPS
Price-to-Sales 214.13
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.68
Resistance 3 (R3) 30.66 29.28 30.00
Resistance 2 (R2) 29.28 28.24 29.29 29.77
Resistance 1 (R1) 27.94 27.60 28.61 27.96 29.55
Pivot Point 26.56 26.56 26.90 26.57 26.56
Support 1 (S1) 25.22 25.52 25.89 25.24 23.65
Support 2 (S2) 23.84 24.88 23.85 23.43
Support 3 (S3) 22.50 23.84 23.20
Support 4 (S4) 22.52